VueBoxtrademark has been used for contrast analysis in DCE-US-based quantitative research.
OBJECTIVE:
Aim of this study was to use the enhancement-mode and VueBoxtrademark parameters to further evaluate the differential diagnostic value of DCE-US for renal tumors.
METHODS:
24 patients with renal tumors, including 7 benign and 17 malignant, were retrospectively analyzed.The DCE-US enhancement-mode and VueBoxtrademark parameters correlated with the histological analyses of tumors were obtained and analyzed.
RESULTS:
The benign and malignant renal tumors showed significant differences in enhancement degree (P = 0.017) and presence of a pseudocapsule (P = 0.009) and in the VueBoxtrademark parameters FT (P = 0.045) and RT (P = 0.039). Receiver operating characteristic analysis for differential diagnosis of benign and malignant renal tumors showed that AUC for a combination of enhancement degree and presence of a pseudocapsule was greater (AUC = 0.815) than the values for either parameter of enhancement mode alone. Similarly, the AUC for a combination of RT and FT was greater (AUC = 0.798) than the values for RT or FT alone. A comprehensive index obtaining by combining the enhancement-mode and VueBoxtrademark parameters showed the largest AUC (AUC = 0.916) with relatively high accuracy (87.50%), sensitivity (76.50%), and specificity (85.70%).
CONCLUSIONS:
DCE-US with enhancement mode and quantitative analysis can facilitate preoperative differential diagnosis of benign and malignant renal tumors.
SiegelRL, MillerKD, FuchsHE, JemalA. Cancer Statistics, CA: A Cancer Journal for Clinicians2021;71(1):7–33. doi: 10.3322/caac.21654.
2.
SungH, FerlayJ, SiegelRL, LaversanneM, SoerjomataramI, JemalA, BrayF. Global Cancer Statistics GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA Cancer J Clin2021;71(3):209–49. doi: 10.3322/caac.21660.
3.
ShenL, LiY, LiN, ZhaoY, ZhouQ, LiZ. Clinical utility of contrast-enhanced ultrasonography in the diagnosis of benign and malignant small renal masses among Asian population, Cancer Medicine2019;8(18):2–41. doi: 10.1002/cam4.2635.
4.
SavadjievP, ChongJ, DohanA, AgnusV, ForghaniR, ReinholdC, GallixB. Image-based biomarkers for solid tumor quantification, European Radiology2019;29(10):5431–40. doi: 10.1007/s00330-019-06169-w.
5.
KasojiSK, ChangEH, MullinLB, ChongWK, RathmellWK, DaytonPA. A Pilot Clinical Study in Characterization of Malignant Renal-cell Carcinoma Subtype with Contrast-enhanced Ultrasound, Ultrasonic Imaging2017;39(2):126–36. doi: 10.1177/0161734616666383.
JungEM, JungF, StroszczynskiC, WiesingerI. Quantification of dynamic contrast-enhanced ultrasound (CEUS) in non-cystic breast lesions using external perfusion software, Scientific reports2021;11(1):17677. doi: 10.1038/s41598-021-96137-6.
8.
DongY, QiuYJ, CaoJY, FanPL, WangWP, FleischmannJ, JungEM. Ultrasound features of abdominal thrombosis in COVID 19 patients, Clinical Hemorheology and Microcirculation2022;82(3):239–48. doi: 10.3233/CH-221487.
9.
LerchbaumerMH, FischerT, UlukD, FriedersdorffF, HammB, SpieseckeP. Diagnostic value of contrast-enhanced ultrasound (CEUS) in kidney allografts-12 years of experience in a tertiary referral center, Clinical Hemorheology and Microcirculation2022;82(1):75–83. doi: 10.3233/CH-211357.
10.
ZhangF, LiR, LiG, JinL, ShiQ, DuL. Value of Contrast-Enhanced Ultrasound in the Diagnosis of Renal Cancer and in Comparison With Contrast-Enhanced Computed Tomography: A Meta-analysis, Journal of ultrasound in medicine: official journal of the American Institute of Ultrasound in Medicine2019;38(4):903–14. doi: 10.1002/jum.14769.
11.
CaoH, FangL, ChenL, ZhanJ, DiaoX, LiuY, LuC, ZhangZ, ChenYThe Value of Contrast-Enhanced Ultrasound in Diagnosing Small Renal Cell Carcinoma Subtypes and Angiomyolipoma, Journal of ultrasound in medicine: official journal of the American Institute of Ultrasound in Medicine2022;41(6):1415–23. doi: 10.1002/jum.15824.
12.
XiaQ, YuanX, HuangM, ZhouX, ZhouZ. Contrast-enhanced Ultrasound for Diagnosis of Renal Cystic Mass, Current Medical Imaging Formerly Current Medical Imaging Reviews2022;18(3):292–8. doi: 10.2174/1573405617666210719141831.
13.
TranquartF, MercierL, FrinkingP, GaudE, ArditiM. Perfusion quantification in contrast-enhanced ultrasound (CEUS)–ready for research projects and routine clinical use, Ultraschall in der Medizin2012;33(Suppl 1):S31–38. doi: 10.1055/s-0032-1312894.
14.
MaxeinerA, FischerT, SchwabeJ, BaurADJ, StephanC, PetersR, SlowinskiT, von LaffertM, Marticorena GarciaSR, HammBet al. Contrast-Enhanced Ultrasound (CEUS) and Quantitative Perfusion Analysis in Patients with Suspicion for Prostate Cancer, Ultraschall in der Medizin2019;40(3):340–8. doi: 10.1055/a-0594-2093.
15.
SchwarzeV, MarschnerC, Negrao De FigueiredoG, IngrischM, RubenthalerJ, ClevertDA. Single-center study: dynamic contrast-enhanced ultrasound in the diagnostic assessment of carotid body tumors, Quantitative Imaging in Medicine and Surgery2020;10(9):1739–47. doi: 10.21037/qims-19-920.
16.
NylundK, SaevikF, LehS, PfefferF, HauskenT, GiljaOH. Interobserver Analysis of CEUS-Derived Perfusion in Fibrotic and Inflammatory Crohn’s Disease, Ultraschall in der Medizin2019;40(1):76–84. doi: 10.1055/s-0044-100492.
17.
HuangY, WangY, LiuL, ZhuL, QiuY, ZuoD, LuX, DongY, JungEM, WangW. VueBox® perfusion analysis ofdynamic contrast enhanced ultrasound provides added value in the diagnosis of small thyroid nodules, ClinHemorheol Microcirc2023;83(4):409–20.
QiuYJ, ZhaoGC, ShiSN, ZuoD, ZhangQ, DongY, LouWH, WangWP. Application of dynamic contrast enhanced ultrasound in distinguishing focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma, Clin Hemorheol Microcirc2022;81(2):149–61.
20.
SidhuP, CantisaniV, DietrichCF, GiljaOH, SaftoiuA, BartelsE, BertolottoM, CalliadaF, ClevertDA, CosgroveD, DeganelloA, OnofrioMD, DrudiFM, FreemanS, HarveyC, JenssenC, JungEM, KlauserAS, LassauN, MeloniMF, LeenE, NicolauC, NolsoeC, PiscagliaF, PradaF, ProschH, RadzinaM, SavelliL, WeskottHP, WijkstraHThe EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update (Long Version), Ultraschall in der Medizin (Stuttgart, Germany: 1980)2018;39(2):e2–e44. doi: 10.1055/a-0586-1107.
21.
ClevertDA, AnastasiMD, JungEM. Contrast-enhanced ultrasound and microcirculation: efficiency through dynamics–current developments, Clinical Hemorheology and Microcirculation2013;53(1-2):171–86. doi: 10.3233/CH-2012-1584.
22.
PutzFJ, ErlmeierA, WiesingerI, VerlohN, StroszczynskiC, BanasB, JungEM. Contrast-enhanced ultrasound (CEUS) in renal imaging at an interdisciplinary ultrasound centre: Possibilities of dynamic microvascularisation and perfusion, Clinical Hemorheology and Microcirculation2017;66(4):.293–302. doi: 10.3233/CH-179103.
23.
WiesingerI, JungF, JungEM. Contrast-enhanced ultrasound (CEUS) and perfusion imaging using VueBox(R), Clinical Hemorheology and Microcirculation2021;78(1):29–40. doi: 10.3233/CH-201040.
24.
WiesingerI, WiggermannP, ZausigN, BeyerL, SalzbergerB, StroszczynskiC, JungE. Percutaneous Treatment of Malignant Liver Lesions: Evaluation of Success Using Contrast- Enhanced Ultrasound (CEUS) and Perfusion Software, Ultraschall in der Medizin - European Journal of Ultrasound2017;39(04):440–7. doi: 10.1055/s-0043-119353.
25.
BacchettaF, MartinsM, RegusciS, JichlinskiP, MeuwlyJY, LuccaI, ValerioM. The utility of intraoperative contrast-enhanced ultrasound in detecting residual disease after focal HIFU for localized prostate cancer, Urologic Oncology2020;38(11):846e841–846e847. doi: 10.1016/j.urolonc.2020.05.010.
26.
WiesingerI, JungF, JungEM. Contrast-enhanced ultrasound (CEUS) and perfusion imaging using VueBox®, Clinical Hemorheology and Microcirculation2021;78(1):29–40. doi: 10.3233/CH-201040.
27.
KimHS, KimJH, JangHJ, HanB, ZangDY. Clinicopathologic Significance of VHL Gene Alteration in Clear-Cell Renal Cell Carcinoma: An Updated Meta-Analysis and Review, International Journal of Molecular Sciences2018;19(9). doi: 10.3390/ijms19092529.
XueLY, LuQ, HuangBJ, LiCX, YanLX, WangWP. Differentiation of subtypes of renal cell carcinoma with contrast-enhanced ultrasonography, Clinical Hemorheology and Microcirculation2016;63(4):361–71. doi: 10.3233/CH-152024.
30.
GulatiM, KingKG, GillIS, PhamV, GrantE, DuddalwarVA. Contrast-enhanced ultrasound (CEUS) of cystic and solid renal lesions: a review, Abdominal Imaging2015;40(6):1982–96. doi: 10.1007/s00261-015-0348-5.
31.
JiangJ, ChenY, ZhouY, ZhangH. Clear cell renal cell carcinoma: Contrast-enhanced ultrasound features relation to tumor size, European Journal of Radiology2010;73(1):162–7. doi: 10.1016/j.ejrad.2008.09.030.
32.
MuraseY, IwataH, TakaharaT, TsuzukiT. The highest Fuhrman and WHO/ISUP grade influences the Ki-67 labeling index of those of grades 1 and 2 in clear cell renal cell carcinoma, Pathology International2020;70(12):984–91. doi: 10.1111/pin.13025.
33.
LiuY, KanY, ZhangJ, LiN, WangY. Characteristics ofcontrast-enhanced ultrasound for diagnosis of solid clear cell renalcell carcinomas </=4 cm: A meta-analysis, Cancer Medicine2021;10(23):8288–99. doi: 10.1002/cam4.4365.
